United States· US:60429-914_55f92bef-1b1d-971d-e063-6394a90a2cc3

Benzonatate

A benzonatate product containing benzonatate, registered in United States by Golden State Medical Supply, Inc..

ATC R05DB01

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBenzonatateATCR05DB01REGISTER NO.US:60429-914_55f92bef…PACKS LISTED1CHECKEDSeptember 27, 2026

Price per daily dose

What a daily dose of benzonatate costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

  • United States: $0.35 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Benzonatate · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • US United States$0.35 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
BENZONATATE
Manufacturer
Golden State Medical Supply, Inc.
Country
United States (US)
ATC code
R05DB01
ATC class
Benzonatate
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    60429-914-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for benzonatate.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Benzonatate · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • TizanidineM03BX02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1ddb38e-8ac7-4ee4-ab64-93863a322dc5
GET /v1/drugs/c1ddb38e-8ac7-4ee4-ab64-93863a322dc5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "200",
  "substance": "BENZONATATE",
  "productndc": "60429-914",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA081297",
  "marketing_category": "ANDA"
}

See everything about benzonatate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.